Bakirtas A, et al. – In the study presented here, the preference of physicians for the controller medication and the factors governing their choice were investigated. The findings demonstrated that surveyed Turkish physicians, the majority of whom were specialists, preferred inhaled corticosteroids (ICS) over leukotriene receptor antagonist–(LTRA) as controller medication in mild persistent asthma. Asthma guidelines, training background (pediatrician versus not) and perceived efficacy and patient compliance seemed to influence their preferences.